DARGAN CHARLES K 4
4 · BIOLARGO, INC. · Filed Mar 27, 2023
Insider Transaction Report
Form 4
BIOLARGO, INC.BLGO
DARGAN CHARLES K
Chief Financial Officer
Transactions
- Award
Option to purchase common stock
2023-03-21+300,000→ 4,331,500 totalExercise: $0.20From: 2023-03-21Exp: 2033-03-21→ Common stock (300,000 underlying)
Footnotes (2)
- [F1]The Option is exercisable according to its vesting schedule: (i) 25,000 shares vested as of March 21, 2023, and then (ii) in equal monthly installments of 25,000 shares beginning March 31, 2023, so long as the Engagement Extension Agreement dated March 21, 2023, between Reporting Person and Issuer, remains in force and effect.
- [F2]This Option was issued to the Reporting Person as compensation to serve as Issuer's Chief Financial Officer from February 1, 2023, through January 31, 2024.